Loading stock data…
$40.74-0.51 (-1.24%)
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Teva Pharmaceutical Industries Limited in the Healthcare sector is trading at $41.12 with a market capitalization of $42.8B. Wall Street consensus targets $47.17 (12 analysts), implying a +14.7% move over the next 12 months. The stock is currently near its 52-week high of $42.02, remaining 20.8% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.14B↑ | $3.98B↓ | $4.71B↑ | $4.48B↑ | $4.18B |
| Gross Profit | $2.15B↑ | $1.97B↓ | $2.66B↑ | $2.30B↑ | $2.10B |
| Operating Income | $149.00M↓ | $759.00M↓ | $1.27B↑ | $1.07B↑ | $899.00M |
| Net Income | -$576.00M↓ | $369.00M↓ | $480.00M↑ | $433.00M↑ | $282.00M |
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosa...